Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
First-in-Class Drugs
Sort By
Newest First
Sign in
1 / 1
1 / 1
FDA New Drug Approvals
Many First-in-Class Drugs Approved by FDA in 2022, but Overall Approval Numbers Down
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-03-23-NI-03
Mar 07, 2023
Drug Development
Novartis Licenses First-in-Class Heart Disease Drug
Emilie Branch
Pharma's Almanac
PAO-M03-19-NI-008
Mar 05, 2019
FDA Analysis
FDA Analysis Shows Reduced Competition for First-in-Class Drugs
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M08-18-NI-002
Jul 31, 2018
